Research programme: HIV vaccine - GlaxoSmithKline/IAVI
Latest Information Update: 16 Nov 2007
At a glance
- Originator GlaxoSmithKline; International AIDS Vaccine Initiative
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 01 Sep 2005 Preclinical trials in HIV infections in United Kingdom (unspecified route)